Aquinox Pharma Cash Flow - Quarterly (NASDAQ:AQXP)

Add to My Stocks
$15.72 $0.43 (2.81%) AQXP stock closing price Jun 18, 2018 (Closing)

For analyzing any company like Aquinox Pharma from an investment perspective, its important to check the cash flow statement. The profit-loss statement shows Aquinox Pharma profits, the balance sheet shows Aquinox Pharma debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Aquinox Pharma had cash and cash equivalents of $32.3M at beginning of the quarter and $66.61M at quarter end of 2018 Q1. Aquinox Pharma cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Aquinox Pharma had an outflow of $-15.58M from operating activities, $- spend due to financing activities, and $29.96M inflow due to investing activities till 2018 Q1.

View and download details of Aquinox Pharma cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities-2.41M--2.54M-1.45M-3.74M4.7M3.08M2.93M--0.54M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net1.44M4.54M3.34M1.95M-2.07M1.44M--2.13M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.04M-0.49M-0.47M-0.45M-0.1M-0.71M-0.61M-0.32M-0.02M-0.02M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments30M64.5M48M16.5M--47.34M-2.73M-2.98M2.02M-47.5M
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares-----75.8M75.8M--99.15M
Issuance (Repayment) of Debt Securities--0.01M-0.01M-0.01M------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities------4.69M-4.53M---6.21M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash------0.05M----0.52M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year32.3M39.52M14.9M11M2M9.23M----
Cash & Equivalents at Year End66.61M52.03M47.1M27.14M20.91M32.3M86.22M22.47M35.69M39.52M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Aquinox Pharma stock price history provides insight into historical stock price fluctuations, and Aquinox Pharma stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Aquinox Pharma saw a negative change in Net Change in Cash and Cash Equivalents of $14.57M till 2018 Q1. Apart from the Aquinox Pharma stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Aquinox Pharma decreased its cash from operating activities to $-15.58M till 2018 Q1. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: Aquinox Pharma generated $29.96M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash flow from financing activities shows the flow of cash between Aquinox Pharma and its owners and creditors and was $- till 2018 Q1. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Aquinox Pharma Cash Flow